New York, NY, United States of America

Aaron Balog

This inventor holds 16 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Epothilone Synthesis. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 2001-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aaron Balog. Retrieved from https://idiyas.com/inventor/aaron-balog

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 62.5


Average Co-Inventor Count = 9.6

ph-index = 9

Forward Citations = 257(Granted Patents)


Location History:

  • New York, NY (US) (2001 - 2010)
  • Lambertville, NJ (US) (2010 - 2013)

Company Filing History:


Years Active: 2001-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
Epothilones
Intermediates
Analogues
Synthesis
Pharmaceuticals
Chemical Compounds
Drug Development
Biotechnology
Medicinal Chemistry
Organic Chemistry
Chemical Synthesis
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Aaron Balog in Cancer Research

Introduction

Aaron Balog is a prominent inventor based in New York, NY, recognized for his significant contributions to cancer research. With an impressive portfolio of 16 patents, Balog's work primarily focuses on the synthesis and application of epothilones, compounds pivotal in the fight against cancer.

Latest Patents

Among his latest patents, Balog has developed innovative processes for the synthesis of epothilone A and B, as well as desoxyepothilones A and B. His patents offer convergent processes for preparing these compounds, including various analogues and intermediates that are crucial for their synthesis. Moreover, his inventions propose novel compositions based on these analogues, addressing methods for treating cancer, especially in cases where the cancer has developed a multidrug-resistant phenotype.

Career Highlights

Aaron Balog is affiliated with the Sloan Kettering Institute for Cancer Research, where he leverages his expertise to advance cancer treatment methodologies. His career is marked by a steadfast commitment to enhancing the efficacy of cancer therapies through innovative chemical processes and compositions.

Collaborations

Throughout his career, Balog has collaborated with esteemed colleagues such as Samuel J. Danishefsky and Peter Bertinato. These partnerships have fostered a dynamic research environment that has led to groundbreaking advancements in the field of oncology.

Conclusion

Aaron Balog's contributions to cancer research through his patents and collaborations highlight his role as a key inventor in the medical field. With a focus on the synthesis of epothilones and their applications, Balog continues to play an essential role in developing effective cancer treatments that address complex resistance issues in patients. His innovative spirit and commitment to research exemplify the characteristics of a true pioneer in scientific inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…